ANDA 88719, held by Usl Pharma. Warfarin Sodium.
As of Nov 16, 2026, ANDA 88719 (Warfarin Sodium), held by Usl Pharma, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Warfarin Sodium2MG ยท tablet;oral | Warfarin Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters